Quote:
Originally Posted by Damien
As pointed out elsewhere the terms of a trade deal would likely seek to make regulation more favourable to American drug and healthcare companies. They won't seek to make the NHS disappear but they will want to protect their interests and maximise profits for the contracts they seek. There are all sorts of things they might push for, most of which I don't really understand to do with how contracts for medicines are made, but a lack of regulation in favour of private business is unlikely to benefit us as taxpayers or patients.
|
The big sticking point during the TTIP talks was the option that private businesses had the option to sue Governments if they did things to negatively impact those businesses.
This is a huge deal in the health industry as public health initiatives can and do affect the profits of the pharmaceutical and healthcare industry who have a vested interest in people being sick